ALISON AROCHA: Open Payments
NPI 1497233274 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 88 payments from 14 companies in 2025. Trend: 2023 $2,615 · 2024 $2,855 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $545 |
| Janssen Biotech, Inc. | 21 | $371 |
| Janssen Scientific Affairs, LLC | 2 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $142 |
| Celltrion USA Inc. | 5 | $112 |
| QOL Medical, LLC | 1 | $92 |
| Phathom Pharmaceuticals, Inc. | 6 | $64 |
| VIVUS LLC | 3 | $60 |
| Medtronic, Inc. | 1 | $52 |
| Braintree Laboratories, Inc. | 2 | $45 |
Products named: TREMFYA, SKYRIZI, LINZESS, RINVOQ, ENTYVIO, VEGZELMA, Sucraid, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
